IDEAS home Printed from
   My bibliography  Save this article

Technical Change and Firm Size: The Pharmaceutical Industry


  • Vernon, John M
  • Gusen, Peter


No abstract is available for this item.

Suggested Citation

  • Vernon, John M & Gusen, Peter, 1974. "Technical Change and Firm Size: The Pharmaceutical Industry," The Review of Economics and Statistics, MIT Press, vol. 56(3), pages 294-302, August.
  • Handle: RePEc:tpr:restat:v:56:y:1974:i:3:p:294-302

    Download full text from publisher

    File URL:
    File Function: full text
    Download Restriction: Access to full text is restricted to JSTOR subscribers. See for details.

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    1. Williamson, John & Bottrill, Anthony, 1971. "The Impact of Customs Unions on Trade in Manufactures," Oxford Economic Papers, Oxford University Press, vol. 23(3), pages 323-351, November.
    2. Marcus H. Miller, 1971. "Estimates of the Static Balance of Payments and Welfare Costs of United Kingdom Entry Into the Common Market," National Institute Economic Review, National Institute of Economic and Social Research, vol. 57(1), pages 69-83, August.
    3. Truman, E. M., 1972. "The production and trade of manufactured products in the EEC and EFTA: A comparison," European Economic Review, Elsevier, vol. 3(3), pages 271-290, November.
    4. Resnick, Stephen A. & Truman, Edwin M., 1973. "An empirical examination of bilateral trade in Western Europe," Journal of International Economics, Elsevier, vol. 3(4), pages 305-335, November.
    Full references (including those not matched with items on IDEAS)


    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.

    Cited by:

    1. Burak Dindaroglu, 2011. "R&D Productivity and Firm Size in Semiconductors and Pharmaceuticals: Evidence from Citation Yields," Working Papers 1101, Izmir University of Economics.
    2. Xing Shi & Yanrui Wu & Dingtao Zhao, 2014. "Knowledge intensive business services and their impact on innovation in China," Service Business, Springer;Pan-Pacific Business Association, vol. 8(4), pages 479-498, December.
    3. Hinloopen, Jeroen & Smrkolj, Grega & Wagener, Florian, 2013. "From mind to market: A global, dynamic analysis of R&D," Journal of Economic Dynamics and Control, Elsevier, vol. 37(12), pages 2729-2754.
    4. repec:spr:scient:v:59:y:2004:i:1:d:10.1023_b:scie.0000013304.40957.0d is not listed on IDEAS
    5. repec:sgh:gosnar:y:2017:i:4:p:99-120 is not listed on IDEAS
    6. Rebecca Henderson & Iain Cockburn, 1993. "Scale, Scope and Spillovers: The Determinants of Research Productivity in the Pharmaceutical Industry," NBER Working Papers 4466, National Bureau of Economic Research, Inc.
    7. Deeds, David L. & Decarolis, DONA & Coombs, Joseph, 2000. "Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms," Journal of Business Venturing, Elsevier, vol. 15(3), pages 211-229, May.
    8. Sangjoon Lee & Jinyoung Kim, 2004. "Research Scientist Productivity and Firm Size: Evidence from Panel Data on Inventors," Econometric Society 2004 Far Eastern Meetings 465, Econometric Society.
    9. Cockburn, Iain M. & Henderson, Rebecca M., 2001. "Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research," Journal of Health Economics, Elsevier, vol. 20(6), pages 1033-1057, November.
    10. Deeds, David L. & Decarolis, Dona & Coombs, Joseph E., 1997. "The impact of firmspecific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry," Journal of Business Venturing, Elsevier, vol. 12(1), pages 31-46, January.
    11. Tapon, Francis & Cadsby, Charles Bram, 1996. "The optimal organization of research: evidence from eight case studies of pharmaceutical firms," Journal of Economic Behavior & Organization, Elsevier, vol. 31(3), pages 381-399, December.
    12. repec:rej:journl:v:19:y:2016:i:62:p:5-24 is not listed on IDEAS
    13. Henderson, Rebecca. & Cockburn, Iain., 1993. "Scale, scope and spillovers : the determinants of research productivity in ethical drug discovery," Working papers 3629-93., Massachusetts Institute of Technology (MIT), Sloan School of Management.

    More about this item


    Access and download statistics


    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:tpr:restat:v:56:y:1974:i:3:p:294-302. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Kristin Waites). General contact details of provider: .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.